Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Efficacy of Venetoclax Based Regimens in Relapsed Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis

Laila Hashim, MBBS, Muhammad Salman Faisal, MD MBBS, Zahoor Ahmed, MD, Insija Ilyas Selene, MBBS, Moazzam Shahzad, MD, Syed Maaz Abdullah, MBBS, Yazan Samhouri, MD, Muhammad Yasir, MD, Ahsan Wahab, MD, Hamid Ehsan, MDMBBS, Karun Neupane, MBBS,MD, Faiz Anwer, MD, Salman Fazal, MD

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-142054

Published: 2020

Journal Articles

Spleen and Symptom Responses of JAK Inhibitors in Myelofibrosis; A Systematic Review of Phase 2 and 3 Trials

Muhammad Ans Sharif, MBBS, Muhammad Salman Faisal, MD MBBS, Yazan Samhouri, MD, Laila Hashim, MBBS, Muhammad Yasir, MD, Muhammad Yasir Anwar, Ali Younas Khan, MD, Moazzam Shahzad, MD, Anum Javaid, MD, Muhammad Aadil Rahman, MBBS, Faiz Anwer, MD, Salman Fazal, MD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-140131

Published: 2020

Journal Articles

Systematic Review of Phase III Trials of Daratumumab Based Regimens in Relapsed Refractory Multiple Myeloma

Karun Neupane, MBBS,MD, Zahoor Ahmed, MD, Rabia Ashraf, MBBS, MD, Amna Khan, MBBS, MD, Moazzam Shahzad, MD, Arafat Ali Farooqui, MD, Muhammad Salman Faisal, MD MBBS, Syed Maaz Abdullah, MBBS, Richi Kashyap, MD, Hamid Ehsan, MDMBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-134305

Published: 2020

Journal Articles

A Systematic Review of Phase III Clinical Trials of Daratumumab Addition to Standard Care Regimen for Newly Diagnosed Multiple Myeloma

Zahoor Ahmed, MD, Karun Neupane, MBBS,MD, Rabia Ashraf, MBBS, MD, Amna Khan, MBBS, MD, Moazzam Shahzad, MD, Arafat Ali Farooqui, MD, Muhammad Salman Faisal, MD MBBS, Shaha Nabeel, MD, Abdur Rehman Jamil, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 7.

https://doi.org/10.1182/blood-2020-134895

Published: 2020

Journal Articles

Efficacy of Daratumumab Based Regimens Compared to Standard of Care for Transplant Eligible Multiple Myeloma in Phase III Clinical Trials: A Meta-Analysis

Zahoor Ahmed, MD, Karun Neupane, MBBS,MD, Rabia Ashraf, MBBS, MD, Amna Khan, MBBS, MD, Abdul Rafae, MD, Moazzam Shahzad, MD, Muhammad Saad Farooqi, MDMBBS, Sundas Ali, MBBS, MD, Saad Javed, MD, Richi Kashyap, MD, Shaha Nabeel, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 36.

https://doi.org/10.1182/blood-2020-141761

Published: 2020

Journal Articles

Efficacy of Daratumumab Based Regimens Compared to Standard of Care for Transplant Ineligible Newly Diagnosed Multiple Myeloma in Phase III Clinical Trials: A Meta-Analysis

Zahoor Ahmed, MD, Karun Neupane, MBBS,MD, Rabia Ashraf, MBBS, MD, Amna Khan, MBBS, MD, Moazzam Shahzad, MD, Muhammad Salman Faisal, MD MBBS, Sana Irfan Khan, MD, Abdul Rafae, MD, Arshia Akbar, MDMBBS, Ahsan Wahab, MD, Hamid Ehsan, MDMBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-137141

Published: 2020

Journal Articles

A Systematic Review of Daratumumab Based Four Drug Regimen for Newly Diagnosed Multiple Myeloma in Phase III Clinical Trials

Karun Neupane, MBBS,MD, Zahoor Ahmed, MD, Amna Khan, MBBS, MD, Rabia Ashraf, MBBS, MD, Moazzam Shahzad, MD, Shaha Nabeel, MD, Arshia Akbar, MDMBBS, Saad Javed, MD, Syed Maaz Abdullah, MBBS, Unaiza Faizan, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-138466

Published: 2020

Journal Articles

Azacitidine Maintenance Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Systematic Review

Muhammad Salman Faisal, MD MBBS, Laila Hashim, MBBS, Yazan Samhouri, MD, Syed Maaz Abdullah, MBBS, Ahsan Wahab, MD, Moazzam Shahzad, MD, Hamid Ehsan, MDMBBS, Zahoor Ahmed, MD, Karun Neupane, MBBS,MD, Asim Tameez Ud Din, MD MBBS, Faiz Anwer, MD, Salman Fazal, MD

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-138616

Published: 2020

NARROW

Efficacy of Venetoclax Based Regimens in Relapsed Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis

Spleen and Symptom Responses of JAK Inhibitors in Myelofibrosis; A Systematic Review of Phase 2 and 3 Trials

Systematic Review of Phase III Trials of Daratumumab Based Regimens in Relapsed Refractory Multiple Myeloma

A Systematic Review of Phase III Clinical Trials of Daratumumab Addition to Standard Care Regimen for Newly Diagnosed Multiple Myeloma

Efficacy of Daratumumab Based Regimens Compared to Standard of Care for Transplant Eligible Multiple Myeloma in Phase III Clinical Trials: A Meta-Analysis

Efficacy of Daratumumab Based Regimens Compared to Standard of Care for Transplant Ineligible Newly Diagnosed Multiple Myeloma in Phase III Clinical Trials: A Meta-Analysis

A Systematic Review of Daratumumab Based Four Drug Regimen for Newly Diagnosed Multiple Myeloma in Phase III Clinical Trials

Azacitidine Maintenance Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Systematic Review

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only